Clinical Characteristics and Outcomes of XXXX .

@entity1 @entity8 @entity1009 @entity1188 @entity810 @entity1011 @entity204 @entity1229 @entity454
BACKGROUND: @entity1188 is a rare condition resulting from an acute disruption of renal blood flow, and the cause and outcome of @entity1188 are not well established. STUDY DESIGN: Case series. SETTING _ @entity1 : 438 @entity1 with @entity1188 in January 1993 to December 2013 at 9 hospitals in Korea were included. @entity1188 was defined by radiologic findings that included single or multiple wedge-shaped parenchymal perfusion defects in the kidney. PREDICTOR: Causes of @entity1188 included cardiogenic (n=244 [55.7%]), @entity8 (n=33 [7.5%]), hypercoagulable (n=29 [6.6%]), and idiopathic (n=132 [30.1%]) factors. OUTCOMES: We used recurrence, @entity810 (AKI; defined as @entity1011 level increase  >=  0.3mg/dL within 48 hours or an increase to 150% of baseline level within 7 days during the sentinel hospitalization), new-onset estimated glomerular filtration rate (eGFR)<60mL/ @entity1009 .73m(2) (for >3 months after @entity1188 in the absence of a history of decreased eGFR), @entity454 ( @entity454 ; receiving hemodialysis or peritoneal dialysis because of irreversible @entity8 ), and mortality as outcome metrics. RESULTS: Treatment included urokinase (n=19), heparin (n=342), @entity1229 (n=330), and antiplatelet agents (n=157). 5% of @entity1 died during the initial hospitalization. During the median 20.0 (range, 1-223) months of follow-up, 2.8% of @entity1 had recurrent @entity1188 , 20.1% of @entity1 developed AKI, 10.9% of @entity1 developed new-onset eGFR<60mL/ @entity1009 .73m(2), and 2.1% of @entity1 progressed to @entity454 . LIMITATIONS: This was a retrospective study; it cannot clearly determine the specific causal mechanism for certain @entity1 or provide information about the causes of mortality. 16 @entity1 were excluded from the prognostic analysis. CONCLUSIONS: Cardiogenic origins were the most important causes of @entity1188 . Despite aggressive treatment, @entity1188 can lead to AKI, new-onset eGFR<60mL/ @entity1009 .73m(2), @entity454 , and @entity204 .
